Kolexia
Calleja Anne
Hématologie
Centre Paoli-Calmettes
Marseille, France
56 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde Leucémie myéloïde Syndromes myélodysplasiques Lymphomes Lymphome B diffus à grandes cellules Hypertrophie

Industries

A+A
2 collaboration(s)
Dernière en 2020
AstraZeneca
2 collaboration(s)
Dernière en 2023
Abbvie
1 collaboration(s)
Dernière en 2023
Sandoz
1 collaboration(s)
Dernière en 2023

Dernières activités

Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
EClinicalMedicine   15 novembre 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.
Bone marrow transplantation   09 août 2023
Real-life challenges using personalized prognostic scoring systems in acute myeloid leukemia.
Cancer medicine   16 novembre 2022
Autologous Stem Cell Transplant in 2nd Line DLBCL in 2022, Still the Standard of Care ? a Monocentric Experience
Annual Meeting Abstracts 2022   15 novembre 2022
Comparison of Risk Stratification Tools (ELN-2022, ELN-2017, Lindsley et al., Papaemmanuil et al. and ALFA classifier) in Predicting Outcomes of Patients with Acute Myeloid Leukemia
Annual Meeting Abstracts 2022   15 novembre 2022
Salvage haploidentical or cord-blood allogeneic stem cell transplantation after a prior alternative allograft in hematologic malignancies: A retrospective study from the SFGM-TC.
European journal of haematology   17 octobre 2022
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL
Blood   23 novembre 2021
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.
Leukemia   09 février 2021
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort.
Annals of hematology   25 janvier 2021
Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma.
Bulletin du cancer   10 décembre 2020